Baidu
map

Heart:吸烟影响氯吡格雷药效

2013-06-14 晓静 译 医学论坛网

  四川大学华西医院黄德嘉教授等评估了吸烟对氯吡格雷的临床和药效反应的影响。结果表明,吸烟似乎确实改变了相关临床疗效和氯吡格雷的药效,论文6月8日在线发表于《心脏》(Heart)杂志。   研究者检索了Medline,EMBASE和Cochrane图书馆。入选了那些记录主要心血管不良事件和通过吸烟状态进行分类的血小板对氯吡格雷反应性的临床和实验室试验。利用随机效应模型进行主要分析。对于临床研究,

  四川大学华西医院黄德嘉教授等评估了吸烟对氯吡格雷的临床和药效反应的影响。结果表明,吸烟似乎确实改变了相关临床疗效和氯吡格雷的药效,论文6月8日在线发表于《心脏》(Heart)杂志。

  研究者检索了Medline,EMBASE和Cochrane图书馆。入选了那些记录主要心血管不良事件和通过吸烟状态进行分类的血小板对氯吡格雷反应性的临床和实验室试验。利用随机效应模型进行主要分析。对于临床研究,根据吸烟状态评估HR;对于实验室研究,评估血小板对氯吡格雷活动性的标准平均差(SMD)和血小板对氯吡格雷高反应性集合OR值。

  结果检索了1869篇文章,包括7项临床研究和12项实验室研究共111 132例已确诊的心血管疾病患者和6658例急性冠脉综合征和/或支架置入患者,对其进行meta分析。

  集合临床结果显示,在当前不吸烟患者中,包括氯吡格雷的强化抗血小板治疗方案与严重心血管不良事件危险降低10%相关(HR 0.90;95% CI 0.85 —0.96),在当前吸烟者中这一临床获益增加了2.9倍(HR 0.71;95% CI 0.62—0.80)。

  实验室研究的集合分析显示,当前吸烟者血小板对氯吡格雷的反应性显著降低(SMD −0.30;95% CI −0.46 —−0.15)),但值得注意的是存在相当多的研究间异质性(P=0.000)。基于4项研究(n=1423)的分析提示,与那些从不吸烟者相比,当前吸烟者血小板对氯吡格雷的高反应性概率显著较低(OR 0.33;95% CI 0.22—0.43)。

The impact of smoking on clinical efficacy and pharmacodynamic effects of clopidogrel: a systematic review and meta-analysis.
CONTEXT
Previous findings regarding the relationship between smoking and clopidogrel effects were considerably discrepant.
OBJECTIVE
To assess the impact of smoking on clinical and pharmacodynamic response to clopidogrel.
DATA SOURCES
Medline, EMBASE and the Cochrane Library through January 2013 were searched. Reference lists of pertinent literatures and abstracts of major cardiovascular conferences were screened.
STUDY SELECTION
Clinical and laboratory studies, which reported major adverse cardiovascular events and on-clopidogrel platelet reactivity categorised by smoking status respectively, were selected.
DATA EXTRACTION
Descriptive and quantitative data were extracted. The main analyses were performed under a random-effects model. For clinical studies, HR estimates were synthesised according to smoking status; for laboratory studies, standardised mean difference (SMD) of on-clopidogrel platelet reactivity and OR for high on-clopidogrel platelet reactivity were pooled. Heterogeneity was quantified by computing I2 statistic.
RESULTS
Of the 1869 citations retrieved, seven clinical studies and 12 laboratory studies involving 111 132 patients with established cardiovascular disease and 6658 patients with acute coronary syndrome and/or stent deployment, respectively, were included for meta-analysis. Pooled clinical results showed that an intensified antiplatelet regimen involving clopidogrel was associated with 10% reduced risk for major adverse cardiovascular events among non-current smokers (HR 0.90; 95% CI 0.85 to 0.96), while this clinical benefit was enhanced by 2.9-fold among current smokers (HR 0.71; 95% CI 0.62 to 0.80). Pooled analysis of laboratory studies revealed that current smokers had significantly lower on-clopidogrel platelet reactivity (SMD -0.30; 95% CI -0.46 to -0.15) but, notably, there was considerable inter-study heterogeneity (I2 76.2%; p=0.000). The analysis based on four studies (n=1423) suggested a significantly lower odds of high on-clopidogrel platelet reactivity among current smokers than those among never smokers (OR 0.33; 95% CI 0.22 to 0.43).
CONCLUSIONS
Smoking appears to positively modify the relative clinical efficacy and pharmacodynamic effects of clopidogrel.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1672285, encodeId=774316e228512, content=<a href='/topic/show?id=2f3a8e59170' target=_blank style='color:#2F92EE;'>#药效#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87591, encryptionId=2f3a8e59170, topicName=药效)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=189026903389, createdName=lsndxfj, createdTime=Fri Mar 28 13:25:00 CST 2014, time=2014-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355771, encodeId=0c231355e7198, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Jun 16 01:25:00 CST 2013, time=2013-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562169, encodeId=46e61562169ff, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Sun Jun 16 01:25:00 CST 2013, time=2013-06-16, status=1, ipAttribution=)]
    2014-03-28 lsndxfj
  2. [GetPortalCommentsPageByObjectIdResponse(id=1672285, encodeId=774316e228512, content=<a href='/topic/show?id=2f3a8e59170' target=_blank style='color:#2F92EE;'>#药效#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87591, encryptionId=2f3a8e59170, topicName=药效)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=189026903389, createdName=lsndxfj, createdTime=Fri Mar 28 13:25:00 CST 2014, time=2014-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355771, encodeId=0c231355e7198, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Jun 16 01:25:00 CST 2013, time=2013-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562169, encodeId=46e61562169ff, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Sun Jun 16 01:25:00 CST 2013, time=2013-06-16, status=1, ipAttribution=)]
    2013-06-16 zhaojie88
  3. [GetPortalCommentsPageByObjectIdResponse(id=1672285, encodeId=774316e228512, content=<a href='/topic/show?id=2f3a8e59170' target=_blank style='color:#2F92EE;'>#药效#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87591, encryptionId=2f3a8e59170, topicName=药效)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=189026903389, createdName=lsndxfj, createdTime=Fri Mar 28 13:25:00 CST 2014, time=2014-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355771, encodeId=0c231355e7198, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sun Jun 16 01:25:00 CST 2013, time=2013-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562169, encodeId=46e61562169ff, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Sun Jun 16 01:25:00 CST 2013, time=2013-06-16, status=1, ipAttribution=)]
    2013-06-16 slcumt

相关资讯

ATS 2013:每年CT筛查吸烟老人或可降低其肺癌死亡率

  《新英格兰医学杂志》在线发表的全国肺癌筛查试验(NLST)的第一轮筛查结果显示,对于曾经大量吸烟的老年美国人而言,每年CT扫描筛查肺癌似乎可降低肺癌死亡率。这一结果同期在美国胸科学会(ATS)2013年会上发布。   据主要研究者、明尼苏达大学公共卫生学院环境卫生学系的Timothy R. Church博士介绍,在3年期间,每年小剂量螺旋CT可比常规胸部X线检查发现明显更多的早期肺癌(N.

J Exp Med:开发出有望阻止人再次吸烟的蛋白肽

2012年10月24日来自加拿大多伦多成瘾和精神健康中心(Centre for Addiction and Mental Health, CAMH)的科学家们鉴定出一种潜在新的方法来阻止人们再次吸烟。在当前的治疗方法中,吸烟者试图戒烟,但是经常不能成功。 加拿大CAMH坎贝尔家庭心理健康研究所资深研究员和多伦大大学精神科教授Fang Liu博士说,“我们开发出一种蛋白肽( protein pep

JBC && BBRC:低水平肺蛋白Fut8增加吸烟诱导的肺气肿

吸烟是肺气肿(emphysema)的一个主要的风险因素。肺气肿是慢性阻塞性肺疾病(chronic obstructive pulmonary disease, COPD)的主要症状之一。尽管吸烟导致不可逆的细胞损伤,但是大约只有五分之一的长期吸烟者患上这种退化性的肺疾病。这表明一些人拥有让他们容易患上这种疾病的遗传因子,但是其他人含有提供保护的DNA变异体。如今,来自日本RIKEN高级科学研究所的

ATS 2013:每年CT筛查可降低吸烟人群的肺癌死亡率

在线发表于2013年5月23日《新英格兰医学杂志》的一项研究显示,对于美国老年烟民或有重度吸烟史的人群,每年行CT筛查可减少相关死亡率。明尼苏达大学公共卫生学院环境卫生学部的Timothy R. Church博士及其同事称,全国肺癌筛查试验(NLST)的第一轮筛查结果显示,3年中,每年小剂量螺旋CT可比常规胸部X线检查发现明显更多的早期肺癌。 他们补充道,在真实的临床情境设定中,“美国有丰富的C

HealthDaily:女性吸烟易患类风湿性关节炎

  一项新的研究显示,吸烟女性和曾吸烟女性都易患类风湿性关节炎,而吸烟量的多少、烟龄长短都会影响类风湿性关节炎的发病概率。类风湿性关节炎会造成关节发炎,导致关节肿胀、僵硬、疼痛,且关节功能也会大受限制。风湿性关节炎不仅会影响关节,还会对身体其他部位造成伤害。   瑞典卡罗林斯卡医学院的研究人员对3.4万名女性的健康资料进行了分析,这些女性的年龄介于54岁到89岁,其中有219人患了类风湿性关节炎

Epidemiology:被动吸烟增加中国女性罹患痴呆的风险

中国是世界上最大的烟草生产国和消费国。1996年的一项全国调查研究表明,在15岁以上的人群中,有67%的中国男性以及4%的中国女性有吸烟史。在不吸烟的女性当中,有54%经常接触二手烟(被动吸烟)。更多近期的数据指出,这一情况并没有发生好转。中国女性吸烟的比例低于男性,但仍然深受二手烟影响。既往研究提示,暴露于二手烟可能会对痴呆的发病产生一定影响。此外,女性发生神经紊乱的风险可能较男性更高。 由于

Baidu
map
Baidu
map
Baidu
map